September 20, 2014 10:34 AM ET

Pharmaceuticals

Company Overview of Arginox Pharmaceuticals, Inc.

Company Overview

Arginox Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for treatment of cardiogenic shocks. Arginox Pharmaceuticals, Inc. was formerly known as Juventis, Inc. The company was incorporated in 2000 and is based in Redwood City, California.

3 Lagoon Drive

Suite 220

Redwood City, CA 94065

United States

Founded in 2000

Phone:

888-274-6070

Fax:

650-517-0101

Key Executives for Arginox Pharmaceuticals, Inc.

Chief Executive Officer and Director
Senior Vice President of Regulatory Affairs
Board Observer
Vice President of Clinical Affairs
Director of Clinical Project Management
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Onset Dermatologics LLC United States
Syndexa Pharmaceuticals Corporation United States
LEO Pharma Inc. United States
PepTech Corp. United States
RP Select Finance Trust United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arginox Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.